
We present a new evidence zzso that, when combined with a set of inclusion criteria, enable drug experts to specify what their confidence in a drug mechanism assertion would be if it were supported by a specific set of zzso We discuss our experience applying the zzso to representing zzso evidence for 16 active pharmaceutical ingredients including six members of the zzso inhibitor family zzso All evidence was collected and entered into the zzso zzso Base zzso a system that can provide customized views of a body of zzso knowledge to users who do not agree about the zzso value of particular evidence zzso We provide specific examples of how the zzso evidence model can flag when a particular use of evidence should be re-evaluated because its related conjectures are no longer zzso We also present the zzso that the zzso uses to identify patterns of evidence support that are indicative of fallacious reasoning by the zzso zzso 

